Dexlansoprazole MR

DRUG11 trials

Sponsors

Takeda, Soonchunhyang University Hospital

Conditions

Esophagitis, PepticEsophagitis, RefluxGastroesophageal RefluxGastroesophageal Reflux DiseaseNonerosive Reflux Disease

Phase 1

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

CompletedNCT00847210

TakedaGastroesophageal Reflux

Start: 2009-05-31End: 2009-09-30Updated: 2012-02-02

Phase 3

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

CompletedNCT00251758

TakedaGastroesophageal Reflux Disease

Start: 2005-12-31End: 2006-05-31Updated: 2010-05-18

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

CompletedNCT00251693

TakedaEsophagitis, Peptic, Esophagitis, Reflux

Start: 2005-12-31End: 2007-01-31Updated: 2012-02-03

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

CompletedNCT00251745

TakedaGastroesophageal Reflux Disease

Start: 2005-12-31End: 2006-05-31Updated: 2011-04-28

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

CompletedNCT00251719

TakedaEsophagitis, Peptic, Esophagitis, Reflux

Start: 2005-12-31End: 2007-01-31Updated: 2012-02-03

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

CompletedNCT00255190

TakedaGastroesophageal Reflux Disease

Start: 2006-01-31End: 2008-06-30Updated: 2016-07-27

Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis

CompletedNCT00255151

TakedaEsophagitis, Peptic, Esophagitis, Reflux

Start: 2006-01-31End: 2006-11-30Updated: 2012-02-03

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

CompletedNCT00255164

TakedaEsophagitis, Peptic, Esophagitis, Reflux

Start: 2006-01-31End: 2006-11-30Updated: 2012-02-03

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

CompletedNCT00321984

TakedaGastroesophageal Reflux Disease

Start: 2006-06-30End: 2006-12-31Updated: 2011-04-28

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

CompletedNCT00321737

TakedaEsophagitis, Peptic, Esophagitis, Reflux

Start: 2006-05-31End: 2007-05-31Updated: 2012-02-03

Unknown Phase

Dexlansoprazole MR in Nonerosive Reflux Disease

Soonchunhyang University HospitalNonerosive Reflux Disease

Start: 2014-12-31Target: 356Updated: 2015-07-03

Related Papers

The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.

2010-11-307 citations